New collagen rope patent for CelGro platform technology
Date Time New collagen rope patent for CelGro platform technology Regenerative medicine company Orthocell (ASX:OCC) has announced Chinese and Hong Kong patents have been granted for its novel CelGro collagen rope device, to augment the surgical repair of anterior cruciate ligament (ACL) injuries. The patents, entitled ‘Collagen Construct and Method for Producing the Collagen Construct’, are now in place in the US, Australia, Japan, China and Hong Kong. They are set to expire on or after 12 October 2035. Orthocell managing director Paul Anderson said, “There are currently no biological o...
Source: miragenews.com